In a sample of 400 phase II trials that included 25,000 participants, a total of 4,045 patients (16.2%) received a treatment ...
Yatsen (NYSE: YSG) Q4 2024 Earnings Call Feb 25, 2025, 7:30 a.m. ET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback